These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15713966)

  • 1. Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer.
    Baggerly KA; Morris JS; Edmonson SR; Coombes KR
    J Natl Cancer Inst; 2005 Feb; 97(4):307-9. PubMed ID: 15713966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer.
    Swiatly A; Horala A; Hajduk J; Matysiak J; Nowak-Markwitz E; Kokot ZJ
    BMC Cancer; 2017 Jul; 17(1):472. PubMed ID: 28683725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic studies of early-stage and advanced ovarian cancer patients.
    Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
    Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic profiling in ovarian cancer.
    Kim G; Minig L; Kohn EC
    Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2(Suppl 2):S2-6. PubMed ID: 19955909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons from controversy: ovarian cancer screening and serum proteomics.
    Ransohoff DF
    J Natl Cancer Inst; 2005 Feb; 97(4):315-9. PubMed ID: 15713968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of proteomic patterns in serum to identify ovarian cancer.
    Petricoin EF; Ardekani AM; Hitt BA; Levine PJ; Fusaro VA; Steinberg SM; Mills GB; Simone C; Fishman DA; Kohn EC; Liotta LA
    Lancet; 2002 Feb; 359(9306):572-7. PubMed ID: 11867112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics of ovarian cancer: functional insights and clinical applications.
    Elzek MA; Rodland KD
    Cancer Metastasis Rev; 2015 Mar; 34(1):83-96. PubMed ID: 25736266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Lessons from controversy: Ovarian cancer screening and serum proteomics.
    Xu R; Gamst A
    J Natl Cancer Inst; 2005 Aug; 97(16):1226; author reply 1227. PubMed ID: 16106029
    [No Abstract]   [Full Text] [Related]  

  • 9. Microvesicle Proteomic Profiling of Uterine Liquid Biopsy for Ovarian Cancer Early Detection.
    Barnabas GD; Bahar-Shany K; Sapoznik S; Helpman L; Kadan Y; Beiner M; Weitzner O; Arbib N; Korach J; Perri T; Katz G; Blecher A; Brandt B; Friedman E; Stockheim D; Jakobson-Setton A; Eitan R; Armon S; Brand H; Zadok O; Aviel-Ronen S; Harel M; Geiger T; Levanon K
    Mol Cell Proteomics; 2019 May; 18(5):865-875. PubMed ID: 30760538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of early relapse in ovarian cancer using serum proteomic profiling.
    Oh JH; Gao J; Nandi A; Gurnani P; Knowles L; Schorge J
    Genome Inform; 2005; 16(2):195-204. PubMed ID: 16901102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive modeling in proteomics-based disease detection.
    Pham TD
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():3308-11. PubMed ID: 18002703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis for early detection of ovarian cancer: a realistic approach?
    Stevens EV; Liotta LA; Kohn EC
    Int J Gynecol Cancer; 2003; 13 Suppl 2():133-9. PubMed ID: 14656269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian cancer detection by logical analysis of proteomic data.
    Alexe G; Alexe S; Liotta LA; Petricoin E; Reiss M; Hammer PL
    Proteomics; 2004 Mar; 4(3):766-83. PubMed ID: 14997498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A data review and re-assessment of ovarian cancer serum proteomic profiling.
    Sorace JM; Zhan M
    BMC Bioinformatics; 2003 Jun; 4():24. PubMed ID: 12795817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
    Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
    J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular diagnostics of ovarian cancer using proteome techniques].
    Vlasova MA; Moshkovskiĭ SA; Safarova MP; Makarov OV; Archakov AI
    Biomed Khim; 2005; 51(4):367-83. PubMed ID: 16223028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer.
    Liotta LA; Petricoin EF; Ardekani AM; Hitt BA; Levine PJ; Fusaro VA; Steinberg SM; Mills GB; Simone C; Fishman DA; Kohn EC
    Gynecol Oncol; 2003 Jan; 88(1 Pt 2):S25-8; discussion S37-42. PubMed ID: 12586081
    [No Abstract]   [Full Text] [Related]  

  • 18. High-resolution serum proteomic patterns for ovarian cancer detection.
    Baggerly KA; Edmonson SR; Morris JS; Coombes KR
    Endocr Relat Cancer; 2004 Dec; 11(4):583-4; author reply 585-7. PubMed ID: 15613439
    [No Abstract]   [Full Text] [Related]  

  • 19. Biomarkers of ovarian tumours.
    Rapkiewicz AV; Espina V; Petricoin EF; Liotta LA
    Eur J Cancer; 2004 Nov; 40(17):2604-12. PubMed ID: 15541961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome profiling of human epithelial ovarian cancer cell line TOV-112D.
    Gagné JP; Gagné P; Hunter JM; Bonicalzi ME; Lemay JF; Kelly I; Le Page C; Provencher D; Mes-Masson AM; Droit A; Bourgais D; Poirier GG
    Mol Cell Biochem; 2005 Jul; 275(1-2):25-55. PubMed ID: 16335783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.